ALPHARETTA, Ga., March 8, 2022 /PRNewswire/ -- Avion Pharmaceuticals, LLC, an Alora Pharmaceuticals company, today announced its support for new guidance from multiple U.S. federal agencies supporting women's access to U.S. Food and Drug Administration (FDA) approved contraceptive products and urging compliance with existing Affordable Care Act (ACA) laws requiring that patients have access to contraceptive products with no out of pocket cost to the patient.
ALPHARETTA, Ga., Feb. 14, 2022 /PRNewswire/ -- Avion Pharmaceuticals, LLC, an Alora Pharmaceuticals company, announced the commercial launch of DHIVY, the first and only carbidopa/levodopa (CD/LD) fractional tablet designed to be divided. Avion gained approval for DHIVY from the FDA in November 2021. This unique design enables more precise medication dosing and directly addresses a market need to assist in titration for the gold standard commonly used by those with Parkinson's Disease (PD), the fastest-growing neurological condition in the United States, for which there is currently no cure.
ALPHARETTA, Ga., Sept. 20, 2021 /PRNewswire/ -- Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, today announced the addition of Divigel® (estradiol gel) 0.1%–the #1 prescribed transdermal estrogen gel*–to the company's growing women's health portfolio.